Healthy Adults Ages 18-45 - Earn up to $2,000- $2,500
If you've previously submitted an application, call 417-831-2048 to enroll. Or submit your application now.
Participant Requirements: Men and Women, ages 18-45, non-tobacco for at least 6 months.. Women must use an acceptable method of birth control such as: double barrier method, bilateral tubal ligation, hysterectomy, bilateral oophorectomy; intrauterine device (IUD) with or without hormones in place or hormonal contraception (oral, injectable, implantable, transdermal, or vaginal); vasectomized partner or bilateral insertion of Essure implants for at least 6 months prior to the first dose; or postmenopausal status with amenorrhea for at least 12 months prior to the first dose. Male subjects must abstain from sperm donation from first dosing and until 90 days after the last dose of study drug. BMI (Body Mass Index) must be between 18.5 - 30.
What: This study will be testing the interaction, absorption and metabolic rate of 4 different medications. An investigational medication used to treat mitochondrial diseases followed by 3 marketed medications used for acid reflex, cholesterol and diabetes.
When: This study will consist 2 Stays and up to 5 outpatient visits . Study dates are as follows:
Group 1Visit Dates
How Much: $2,000 on Wednesday, September 5, 2018
Group 2Visit Dates
How Much: $2,500 on Friday, August 31, 2018
Group 3Visit Dates
How Much: $2,000 on Friday, September 21, 2018
Physical: Tuesday, August 14, 2018 4:00 pm Monday, August 20, 2018 4:00 pm Tuesday, August 21, 2018 4:00 pm
All study dates are tentative and subject to change.
We will update the study list every Wednesday. Be sure to check with us either by calling or by looking online. Call (417) 831-2048 or come by 1820 West Mt. Vernon for more information. Office hours are Monday through Friday, 8:00 a.m. to 5:00 p.m.
Don't forget our REFERRAL PROGRAM. Earn at least $100 for every new participant you refer who completes a study.**No referral bonuses are paid out for outpatient vaccine studies.